Long-term survival in pulmonary hypertension with diabetes
Treatments studied
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at how long people with pulmonary hypertension (high blood pressure in the lungs) and diabetes live, and what factors might affect their survival. If you have both conditions, joining this study could help doctors better understand your prognosis and improve care for others like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have a diagnosis of pulmonary hypertension (high blood pressure in the lungs) from a doctor.
- You must not have any type of cancer.
- You must be able to make your own medical decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sleep-disordered breathing (abnormal breathing during sleep) affects the long-term health of people with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. By participating, you will have a sleep study and be followed over time to see how your breathing during sleep relates to your PAH outcomes.
This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.
This study follows adults with pulmonary hypertension over the long term and collects information (and possibly samples) to better understand how the condition changes over time. It may help researchers learn what factors affect outcomes, which can improve care in the future.
This is a long-term study that enrolls people who have been diagnosed with pulmonary hypertension (high blood pressure in the lung arteries). It collects medical information over time to better understand the condition and what to expect.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
This study aims to better predict the future risk for people with pulmonary hypertension (high blood pressure in the lungs) by combining different types of health information collected over time. If you join, researchers will track your health data to build a tool that personalizes care and improves outcomes.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.